Cited by CrossRef (8)
- Ji-Hye Lee. Invertebrate Model Organisms as a Platform to Investigate Rare Human Neurological Diseases. Exp Neurobiol 2022;31:1
- Valentina Cesaroni, Fabio Blandini, Silvia Cerri. Dyskinesia and Parkinson’s disease: animal model, drug targets, and agents in preclinical testing. Expert Opinion on Therapeutic Targets 2022;26:837
- Sazan Ismael, Robert A. Colvin, Daewoo Lee. Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson’s disease. Brain Research 2024;1822:148641
- Naoko Nozawa, Marie Noguchi, Kanako Shinno, Maki Tajima, Shingo Aizawa, Taro Saito, Akiko Asada, Takuya Ishii, Masahiro Ishizuka, Koichi M. Iijima, Kanae Ando. 5‐Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila. FEBS Open Bio 2022;12:295
- Aaron Taehwan Kim, Sida Li, Yoo Kim, Young-Jai You, Yeonhwa Park. Food preference-based screening method for identification of effectors of substance use disorders using Caenorhabditis elegans. Life Sciences 2024;345:122580
- Fanhao Kong, Hui Jin, Yifan Xu, Jie Shen. Behavioral toxicological tracking analysis of Drosophila larvae exposed to polystyrene microplastics based on machine learning. Journal of Environmental Management 2024;359:120975
- Luca Lo Piccolo, Ranchana Yeewa, Sureena Pohsa, Titaree Yamsri, Daniel Calovi, Jutarop Phetcharaburanin, Manida Suksawat, Thanaporn Kulthawatsiri, Vorasuk Shotelersuk, Salinee Jantrapirom. FAME4-associating YEATS2 knockdown impairs dopaminergic synaptic integrity and leads to seizure-like behaviours in Drosophila melanogaster. Progress in Neurobiology 2024;233:102558
- Woongchang Yoon, Soohong Min, Ho-Sung Ryu, Sun Ju Chung, Jongkyeong Chung. Discovery of levodopa-induced dyskinesia-associated genes using genomic studies in patients and Drosophila behavioral analyses. Commun Biol 2022;5